Henry Schein Inc (HSIC) · Aug 4, 2026 · Earnings

Q2 beat modestly, then lifted full-year EPS and sales outlook

Beat — Non-GAAP EPS $1.27 vs approximately $1.25 consensus

Q2 beat modestly, then lifted full-year EPS and sales outlook

The quarter cleared expectations, but not by a wide margin. Non-GAAP diluted EPS was $1.27 versus a published consensus of roughly $1.25, while revenue was $3.458 billion versus approximately $3.44 billion expected. That makes the earnings result a narrow beat rather than a major upside surprise.

MetricQ2 2026Comparison / expectation
Revenue$3.458B$3.240B prior year; approximately $3.44B consensus (Income Statement; Exhibit A)
Non-GAAP diluted EPS$1.27$1.10 prior year; approximately $1.25 consensus (Exhibit B)
GAAP diluted EPS$0.82$0.70 prior year (Income Statement; Exhibit B)
Adjusted EBITDA$288M$256M prior year (Exhibit C)
FY2026 non-GAAP EPS guidance$5.29–$5.39Raised from $5.23–$5.37 (2026 Financial Guidance)
FY2026 sales-growth guidance4.5%–5.5%Raised from 3%–5% (2026 Financial Guidance)

The more important surprise was the raised outlook. Management lifted the full-year EPS range at both ends, raised the sales-growth range, and upgraded Adjusted EBITDA growth from mid-single digits to mid- to high-single digits. That is a genuine change to the forward expectation, not merely a confirmation of the existing plan (2026 Financial Guidance).

Underlying demand improved, though currency helped the headline. Q2 internal sales growth accelerated to 4.6%, with particularly strong global dental merchandise growth of 5.9% and technology internal growth of 9.1%; total reported sales growth of 6.7% also included a 1.4% foreign-exchange benefit (Financial Highlights; Exhibit A). U.S. equipment remained weak, declining 1.1%, which limits how broadly the strength can be characterized (Exhibit A).

The net read is a modest earnings beat with a clearer upgrade to the year. Q2 non-GAAP earnings growth was 15.5%, and Adjusted EBITDA rose 12.5%, while share repurchases reduced diluted shares by roughly 6.7% year over year, providing some EPS support (Exhibit B; Exhibit C; Income Statement). The combination of a small quarterly beat and higher full-year targets makes this better than merely in line, although the absence of a GAAP reconciliation for the new outlook leaves restructuring and value-creation costs as an ongoing uncertainty (2026 Financial Guidance).

What to watch next

Q3 report, early November

Original filing on SEC EDGAR

More Henry Schein Inc news

Q2 beat modestly, then lifted full-year EPS and sales outlook | HSIC Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.